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BACKGROUND: Obese women experience higher post-
menopausal breast cancer risk, morbidity, and mortality
and may be less likely to undergo mammography.
OBJECTIVES: To quantify the relationship between
body weight and mammography in white and black
women.
DATA SOURCES AND REVIEW METHODS: We identi-
fied original articles evaluating the relationship between
weight and mammography in the United States through
electronic and manual searching using terms for breast
cancer screening, breast cancer, and body weight. We
excluded studies in special populations (e.g., HIV-
positive patients) or not written in English. Citations
and abstracts were reviewed independently. We ab-
stracted data sequentially and quality information
independently.
RESULTS: Of 5,047 citations, we included 17 studies
in our systematic review. Sixteen studies used self-
reported body mass index (BMI) and excluded women
<40 years of age. Using random-effects models for the
six nationally representative studies using standard
BMI categories, the combined odds ratios (95% CI) for
mammography in the past 2 years were 1.01 (0.95 to
1.08), 0.93 (0.83 to 1.05), 0.90 (0.78 to 1.04), and 0.79
(0.68 to 0.92) for overweight (25–29.9 kg/m
2), class I
(30–34.9 kg/m
2), class II (35–39.9 kg/m
2), and class III
(≥40 kg/m
2) obese women, respectively, compared to
normal-weight women. Results were consistent when all
available studies were included. The inverse association
was found in white, but not black, women in the three
studies with results stratified by race.
CONCLUSIONS: Morbidly obese women are significantly
less likely to report recent mammography. This relation-
ship appears stronger in white women. Lower screening
ratesmaypartlyexplainthehigherbreastcancermortality
in morbidly obese women.
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INTRODUCTION
Breast cancer remains the second leading cause of cancer
death among women in the United States
1. Screening mam-
mography reduces breast cancer mortality
2–6, and current
guidelines recommend mammography every 1–2 years for
women over 40 years of age
7,8.
Obesity has increased over the past 2 decades among
women in the US
9 and has disparate effects on pre- and
postmenopausal breast cancer. Excess body weight may actually
decrease the risk of premenopausal breast cancer
10,11, but the
relationship between obesity and premenopausal breast cancer
mortality is ambiguous
11,12. However, obesity is an important
risk factor for both the development of
10,11,13–15 and mortality
from
16–19 postmenopausal breast cancer. Obesity may also
worsen breast cancer morbidity, including risk of breast cancer
recurrence
20, contralateral breast cancer
21, wound complica-
tions after breast surgery
22,a n dl y m p h e d e m a
23,24.
The mechanism by which obesity leads to poorer prognosis
of breast cancer is not well understood and may be related to
tumor characteristics, hormonal mechanisms, suboptimal diet
and physical activity, or delay in diagnosis
16. Studies of the
relationship between obesity and stage at breast cancer
diagnosis are conflicting
25,26.
Several observational studies suggest that obese women
may be less likely to report recent mammography
27–39, but the
relationship between obesity and screening mammography
remains unclear
40–43. Some studies suggest the problem may
be confined to white women
31–33,36.
Therefore, we conducted a systematic review and meta-
analysis to determine whether overweight or obese women are
less likely to have recent mammography than their normal-
weight counterparts. We also studied the effect of race on the
relationship between weight and recent mammography.
Preliminary results from this project were presented in a poster at the
2007 Society of General Internal Medicine national meeting in Toronto on
April 26, 2007.
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665METHODS
Search Strategy
Our overall search strategy addressed a broader question
regarding the association between obesity and screening for
breast, cervical, and colon cancer. For this study, we searched
the PubMed, CINAHL, and Cochrane Library electronic data-
bases from inception to July 2008 to identify original articles
evaluating the relationship between body weight and recent
mammography in the US using search terms for breast cancer
screening, breast cancer, and body weight (Appendix Table 5).
We manually searched the references of included articles and
the tables of contents of 11 key medical journals from August
2006 through November 2006 and then updated our manual
search from April 2008 to July 2008. General medical, cancer,
women’s health, and prevention journals were selected based
on the origin of the included articles and the topic itself to
avoid missing articles due to any delays in electronic indexing.
Searchers were physician investigators and included a senior
obesity researcher (J.M.C.), an investigator with systematic
review experience (S.B.), and a post-doctoral epidemiology
trainee with relevant clinical experience (N.M.M). Two
reviewers conducted title and abstract reviews independently.
If a title was selected by either investigator, it was advanced to
abstract review. Title and abstract reviews were designed to be
sensitive; if there was any question of an article exploring
weight as a predictor of screening upon title or abstract review, we
advanced the article to the next level of review. Of 273 abstracts,
there were 62 conflicts (23%) in abstract review, which we resolved
by consensus through discussion. Disagreements usually per-
tained to misreading on the part of one of the investigators, and
disagreements in judgment were rare.
Study Selection
We included published original articles if they reported the
prevalence of mammography by body weight in adults
≥18 years of age and were written in English. We defined
original articles as articles in which the authors analyzed raw
data and thus excluded reviews, commentaries, editorials, and
consensus statements. We excluded studies conducted outside
of the US since other countries may have different screening
guidelines and resources, and the relationship between weight
and mammography might differ based on cultural norms. We
also excluded studies of screening in special populations since
there may be different screening expectations for some popula-
tions (e.g., participants presenting to a cancer screening clinic,
HIV-positive patients, those with a history of breast cancer,
and those involved in a study of interventions to improve
screening). Two investigators reviewed articles independently.
Of 101 articles, there were 3 disagreements (3%), which were
resolved through discussion.
Data Abstraction and Quality Assessment
Two reviewers sequentially abstracted the data on population
characteristics, the exposure, and the outcome using stan-
dardized data abstraction forms. Two studies included body
mass index (BMI) in models when exploring determinants of
screening, but did not explicitly report mammography preva-
lence by BMI; the authors kindly provided these results
34,39.
Two reviewers evaluated study quality independently using
a quality form (Appendix A) based on the STrengthening the
Reporting of OBservational studies in Epidemiology (STROBE)
Statement, Checklist of Essential Items version 3 (September
2005)
44, which was published recently
45. We assumed that the
importance of any confounding variable varied according to
study design. Therefore, we did not expect each study to
handle confounding in the same fashion and assessed quality
as being adequate, fair, or inadequate on an individual basis.
We resolved disagreements in data abstraction and quality
evaluation through discussion.
Data Synthesis and Analysis
First, we created tables to describe all studies qualitatively. We
reported results of adjusted analyses when available. In order
to obtain generalizable combined estimates for the association
between weight and mammography, we conducted unstratified
meta-analyses and meta-analyses stratified by white and black
race for studies that: (1) had nationally representative data
and (2) reported BMI in five standard categories according to
the World Health Organization
46 and the National Institutes of
Health
47:(normal:18.5–24.9kg/m
2,overweight:25–29.9kg/m
2,
class I obesity: 30–34.9 kg/m
2, class II obesity: 35–39.9 kg/m
2,
and class III obesity: ≥ 40 kg/m
2). We contacted the authors of
articles that did not report results for mammography by BMI in
five standard categories; two authors provided the quantitative
results requested
28,40. Two authors were unable to provide
quantitative results stratified by race
30,33.
Using the DerSimonian and Laird method
48, we used
random-effects models to calculate combined odds ratios and
95% confidence intervals for mammography by BMI category
using normal BMI as the reference category. For the study that
reported adjusted proportions
33, we calculated odds ratios. We
converted the relative risk to an odds ratio
49 for another
study
32. One study provided results stratified by race only
31,
and we included the results from the white and black cohorts
separately in our main and race-specific analyses.
We tested for heterogeneity using the I
2 statistic
50 with an I
2
value of >50% signifying “substantial heterogeneity”
51.W e
chose a random-effects model as a more conservative approach
to account for potential between-study variability.
We tested for publication bias using the tests of Begg and
Mazumdar
52 and Egger and colleagues
53. All analyses were
completed using STATA (StataCorp. 2005. Stata Statistical
Software: Release 9. College Station, TX: StataCorp LP).
We conducted several sensitivity analyses. We examined the
effect of the removal of any one study on the combined
estimate for the unstratified analyses. Also, two
35,37 of the
seven studies
30–33,35,37,38 that were based on nationally repre-
sentative data and reported BMI in five categories used the
same 2000 National Health Interview Survey (NHIS) data but
performed slightly different analyses. We included the study
with more conservative results in the main meta-analysis
35.W e
included the other, less conservative estimate from the other
study
37ina separateanalysis.Inanotheranalysis,weincludedall
studies that provided BMI in five standard categories regardless of
whether they were nationally representative.
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Literature Search Results
Of 5,047 titles identified in the overall search, 17 articles met
our inclusion criteria and addressed mammography (Fig. 1).
Seven
30–33,35,37,38 of the 17 studies were sufficiently homoge-
neous (i.e., used nationally representative survey data and
provided information for mammography by five standard
categories of BMI) to include in the unstratified meta-analyses.
Two of these studies were based on the same 2000 NHIS
data
35,37; thus, six studies were included in our main meta-
analyses. Five nationally-representative studies
30–33,35
reported race-stratified analyses, and two of these
30,33 did
not report the necessary quantitative results to allow their
inclusion in the meta-analyses; thus, we included three
studies in our race-stratified meta-analysis. Six studies were
not nationally representative and were conducted in primarily
non-white populations
34,39,40,42,43 or reported race-stratified
results
36.
Study Characteristics
The 17 included studies, which comprised approximately
276,034 participants, are described in Tables 1 and 2. Sixteen
studies were cross-sectional
27–38,40–43, and one was longitudi-
nal
39. All studies used BMI as the measure of excess body
weight. Thirteen studies defined the outcome as mammography
in the last 2 years
28–33,35–38,40,42,43, two as mammography in the
last year
27,34, one as mammography in the last 3 years
41,a n d
one as mammography every 2 years over a 6-year period
39.
Figure 1. Study flow diagram. *Search terms for breast cancer, cervical cancer, colon cancer, body weight, breast cancer screening,
cervical cancer screening, and colon cancer screening were used to conduct the search of electronic databases. Specific terms are
provided in Appendix Table 5.
†Manual searching involved searching of references of included and key articles and searching of tables of
contents of the following journals: Cancer, Journal of General Internal Medicine, Annals of Internal Medicine, Obesity, Ethnicity and Disease,
Cancer Detection and Prevention, Journal of Health Care for the Poor and Underserved, Preventing Chronic Disease, Journal of Women’s
Health, American Journal of Public Health, Preventive Medicine, and American Journal of Epidemiology.
‡Reasons for exclusion add up to
more than abstracts or articles excluded since reviewers could have more than one reason for exclusion.
§Studies included in the main meta-
analysis reported nationally-representative results in five standard body mass index categories (normal 18–24.9 kg/m
2, overweight 25–
29.9 kg/m
2, class I obesity 30–34.9 kg/m
2, class II obesity 35–39.9 kg/m
2, class III obesity ≥ 40 kg/m
2). A seventh study
37 met these criteria, but
was based on the same data as another study
35 and therefore was only included in a sensitivity analysis.
║Studies included in the race-
specific meta-analysis reported nationally representative results in five standard body mass index categories (normal 18–24.9 kg/m
2,
overweight 25–29.9 kg/m
2, class I obesity 30–34.9 kg/m
2, class II obesity 35–39.9 kg/m
2, class III obesity ≥40 kg/m
2).
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27,29–33,35,37,38,41 of the 17 studies (59%) were based on
nationally representative surveys, the NHIS, Behavioral Risk
Factor Surveillance System (BRFSS), or Health and Retirement
Survey. Most subjects were white. Reported absolute screened
proportions ranged from 53.2% to 85.6%
29,30,32–34,36–41,43.
Sixteen of the 17 studies
27–39,41–43 (94%) relied on self-
reported BMI and mammography. Fourteen studies accounted
for confounding adequately
27,29–41, and one study did not
adjust for any confounding factors
28. Reported survey re-
sponse rates ranged from 55% to 88%. Eight studies did
Table 1. Description of Studies Included in Qualitative and Quantitative Analyses*
Author, year Study population Mean age, y (range) Race/ethnicity (%) Exclusion criteria
Amonkar
et al. 2002
27
9,908 respondents to the
1997 BRFSS
NR (40–80+) White 83.8%; black
15%; Asian/Pacific
Islander 0.4%;
American Indian 0.4%;
other 0.4%
<40 years of age
Amy et al.
2006
28
338 respondents to survey
available in clothing stores,
a convention, magazine, and
research database
45(21–80)
† White 68%
‡ <40 years of age, BMI<25 kg/m
2
Berz et al.
2008
§38
105,899 respondents to the
2004 BRFSS
59.3(40–99)
† White 75.2%; black
7.3%; Hispanic 9.7%;
others 7.8%
‡
<40 years of age, missing
BMI, mammography response,
or any confounding variable
Cohen et al.
2007 (36)
25,060 participants in the
Southern Community Cohort
Study
NR (42–70+)
† White 25.2%; black
74.8%
<42 or >79 years of age, BMI<18.5 kg/m
2,
not black or white, diagnosis of breast
cancer, treatment for cancer in last
year, missing BMI or mammography use,
not English-speaking
Coughlin
et al. 2004
29
49,564 respondents to the
1999 BRFSS
NR NR <40 years of age
Ferrante
et al. 2006
40
1,809 patients in 3 urban
New Jersey academic family
medicine practices from
2000–2003
53.4(40–74)
† Hispanic 50%; black
36%
‡
<40 or ≥75 years of age, breast or
cervical cancer, pregnant, missing
weight, no visit in 12 months before
index visit, new patient
Ferrante
et al. 2007
37
8,289 respondents to the
2000 NHIS
NR(40–74)
† White 31.3%; black
26%; Hispanic 28.7%;
other 14%
‡
<40 or ≥75 years of age, BMI<18.5 kg/m
2
Fontaine
et al. 1998
41
3,105 respondents to the
1992 NHIS
46.2(18–97)
† White 79.9%
‡ NR
Fontaine
et al. 2001
§30
38,682 respondents to the
1998 BRFSS
47.7
† (NR) White 84.4%; non-white
15.6%
<40 years of age
Gorin et al.
2001
42
408 respondents to Harlem
Survey from 46 blocks in
Central Harlem in 1991
NR NR
║ <40 or >65 years of age, not English-
speaking, unable to answer questions
Ostbye et al.
2005
§31
8,449 participants in the Health
and Retirement Study (1996,
2000 waves)
NR(50–64)
¶ White 82%; black 18%
¶ Lack of response to 1996 and/or 2000
waves of HRS
Rosenberg
et al. 2005
39
14,706 participants in the
Black Women’s Health Study
1995–2001
NR(40–69)
† Black 100% <40 years of age, not African American,
lack of valid address, lack of completion
of survey
Satia et al.
2007
43
405 enrollees in cancer
risk behavior surveillance study
in North Carolina in 2003
NR(41–70) Black 100% <40 years of age, not African American,
not on Department of Motor Vehicles roster
in one six counties in North Carolina
Wee et al.
2000
§33
3,077 respondents to the
1994 NHIS
62 White 81%; black 10% <50 or >75 years of age
Wee et al.
2004
§32
5,277 respondents to 1998
NHIS Sample Adult and
Prevention questionnaires
61(50–75) White 80%; black
10%; Hispanic/Asian/
other 10%
<50 or >70 years of age
Winkleby
et al. 2003
34
169 women responding
to a community random-digit-
dial survey in Monterey
California
NR(18–64)
† Latino 100% <40 years of age, not Latino, not living
in Monterey County, California
Zhu et al.
2006
§35
9,188 respondents to the
2000 NHIS
NR(40–80)
† White 83.7%; black
16.3%
<40 or >80 years of age, not white or black,
history of breast cancer, mammography
for reason other than screening
*Characteristics of participants included in the main analysis unless otherwise noted
†Mean age and range from overall study
‡Race from overall study
§Studies included in the main, unstratified meta-analysis
║Authors stated, “…majority of women in the survey were non-Hispanic blacks.”
¶From 1996 wave of Health and Retirement Study
BRFSS, Behavioral Risk Factor Surveillance System; NR, not reported; BMI, body mass index; NHIS, National Health Interview Survey; HRS, Health and
Retirement Study
668 Maruthur et al.: Obesity and Mammography JGIMTable 2. Results of Studies Included in Qualitative and Quantitative Analyses
Author,
year
BMI (kg/m
2)* Outcome assessment Outcome
measure
Outcome estimate (95% CI)
. Adjustments
Amonkar
et al. 2002
27
Self-report,
standard 2
categories
Self-report of
mammogram in
last year
OR 0.81 (0.69 to 0.95) Age, race, education, marital
status, residential status,
smoking, health status,
health-care utilization
Amy et al.
2006
28
Self-report,
standard 5
categories
‡
Self-report
of mammogram in
last 2 years
Proportion Overweight 94%, class I
82%, class II 80%, class III
78% P=0.24
§
None
Berz et al.
2008
║38
Self report,
standard 5
categories
Self-report
of screening
mammogram in
last 2 years
OR Normal 1.00, overweight 1.08
(1.01 to 1.15), class I 1.08
(0.99 to 1.18), class II 1.10
(0.98 to 1.25), class III 0.97
(0.84 to 1.13)
Age, race, education, income,
smoking, general health perception
Cohen et al.
2007
36
Self-report,
standard 5
categories
Self-report of
mammogram in
last 2 years
OR Whites: normal 1.00,
overweight 0.89 (0.76 to 1.05),
class I 0.99 (0.83 to 1.18),
class II 0.96 (0.78 to 1.18),
class III 0.70 (0.56 to 0.87)
Age, education, income, smoking
status, number of live births,
co-morbid conditions, family
history of breast cancer, time
since last physician visit, type
of insurance Blacks: normal 1.00,
overweight 1.12 (1.00 to
1.25), class I 1.25 (1.12 to
1.40), class II 1.22 (1.07 to 1.38),
class III 1.06 (0.93 to 1.21)
Coughlin
et al. 2004
29
Self-report,
BMI categories:
>18.5-<25,
25–30, >30
Self-report
of mammogram
in last 2 years
Adjusted
proportion
>18.5-<25: 76.0% (75.1 to
76.8), 25–29: 76.6% (75.7 to
77.5), >30: 74.6% (73.5 to
75.8) P<0.001
¶
Age, race, education, marital
status, income, employment,
smoking, physical activity,
alcohol, use of preventive services,
number of children, number of
persons in household, health
status, diabetes, physician
visit in last year, insurance
Ferrante
et al. 2006
40
Chart review,
standard 5
categories
‡
Mammogram in
last 2 years
recorded in chart
OR Normal 1.00, overweight 1.61
(1.03 to 2.54), class I 1.32 (0.84
to 2.07), class II 1.92 (1.12 to
3.28), class III 1.53 (0.88 to 2.65)
Age, race, marital status,
smoking, co-morbid conditions,
physician visits, insurance
Ferrante
et al. 2007
37
Self-report,
standard 5
categories
Self-report of
mammogram in
last 2 years
OR Normal 1.00, overweight
0.95 (0.81 to 1.10), class I
1.01 (0.83 to 1.23), class II
0.79 (0.60 to 1.05), class III
0.50 (0.37 to 0.68)
Age, race/ethnicity, education,
marital status, smoking, vitamin
use, number of visits, contact
with primary care doctor, family
history of breast cancer, insurance
Fontaine
et al. 1998
41
Self-report, BMI
groups: 25
(reference), 35,
and 40
Self-report of
no mammogram
in last 3 years
#
OR 25: 1.0, 35: 0.81 (0.59 to
1.12), 45: 0.73 (0.45 to 1.19)
Age, race, education, income,
smoking status, insurance status
Fontaine
et al. 2001
║30
Self-report,
standard 5
categories
Self-report of no
mammogram in
last 2 years
#
OR Normal 1.00, overweight 1.00
(0.94 to 1.07), class I 1.12
(1.02 to 1.23), class II 1.13
(0.98 to 1.30), class III 1.32
(1.09 to 1.59)
Age, race, smoking, insurance
Gorin et al.
2001
42
Self-report, BMI
categories: ≤27.3
and >27.3
Self-report of
mammogram in
last 2 years
OR Not overweight: 1.00,
overweight: 3.60 (0.57 to 22.64)
Age, marital status, employment,
fruit/vegetable intake, insurance
Ostbye et al.
2005
║31
Self-report,
standard 5
categories
Self-report of
mammogram in
last 2 years
OR Whites: normal 1.00,
overweight 0.90 (0.78 to
1.05), class I 0.73 (0.60 to
0.88), class II 0.69 (0.51 to 0.93),
class III 0.59 (0.40 to 0.88)
Age, education, marital status,
income, smoking, physical
activity, health status, co-morbid
conditions, physician visits,
hospitalization, insurance
Blacks: normal 1.00, overweight
1.13 (0.79 to 1.62), class
I 0.97 (0.65 to 1.45), class II
1.03 (0.61 to 1.76), class III
1.07 (0.60 to 1.92)
Rosenberg
et al. 2005
39
Self-report,
standard 5
categories
‡
Self-report of
mammogram every
2 years from
1995–2001
OR Normal 1.00, overweight
1.09 (0.98 to 1.22), class I
1.08 (0.95 to 1.23), class II
1.13 (0.95 to 1.34), class III
0.96 (0.79 to 1.16)
Age, education, region, income,
neighborhood SES score,
childcare responsibilities, smoking,
multivitamins, Pap smear, cystic
breast disease, breast self exam,
hormone use, family history of
breast cancer, insurance
(continued on next page)
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27,31,32,35,37,39,41,43, seven had
<10% missing data
28–30,32,34,36,42, and two reported >20%
missing data
38,40. All studies provided an adequate exposure
description, and all but one
27 provided an adequate outcome
description. Ten studies used nationally representative
surveys
27,29–33,35,37,38,41, and 14 did not report the validity of
the surveys used
27,29–33,35–39,41–43. See Table 3.
Quantitative Assessment of Mammography
by BMI
Fourteen
27–39,43 of 17 studies reported an inverse association
between recent mammography and increasing BMI that
was statistically significant in five
27,29,31,36,37.S e v e n
studies
30–33,35,37,38 used nationally representative surveys
with BMI in five standard categories. Using the six studies
based on unique data, class III obesity was inversely associat-
ed with the likelihood of having recently undergone mammog-
raphy compared to women with a normal BMI. The seventh
study by Ferrante et al.
37 was excluded from the main analysis
because it was based on the same data as the study by Zhu et
al.
35. Combined odds ratios for mammography (95% confi-
dence interval) by BMI category were 1.01 (0.95 to 1.08), 0.93
(0.83 to 1.05), 0.90 (0.78 to 1.04), and 0.79 (0.68 to 0.92) for
overweight, class I, class II, and class III obese women,
respectively, compared to women with a normal BMI (Fig. 2). We
found statistical evidence of heterogeneity for the class I and II
obesitycategories; I
2 statistics were 41%, 74%, 59%, and 42% for
the overweight, and class I, II, and III obesity categories,
respectively. The exclusion of any one study did not change the
results of the meta-analyses substantially (data not shown). No
statistically significant publication bias was found, although
evaluation was limited by the relatively small number of studies.
Sensitivity Analyses
We obtained similar results when we excluded the article by
Zhu et al.
35 and instead included the article by Ferrante et
al.
37, which used the same data. Results were also similar
when we included all nine studies with BMI in five categories
Table 2. (continued)
Author,
year
BMI (kg/m
2)* Outcome assessment Outcome
measure
Outcome estimate (95% CI)
. Adjustments
Satia et al.
2007
43
Self-report,
BMI categories:
normal 18.5–
24.9, overweight
25–29.9, obese
>30
Self-report of
mammogram in
last 2 years
OR Normal 1.00, overweight
1.5 (0.6 to 3.6), obese 0.5
(0.2 to 1.3) P=0.39
**
Age, education, BMI
Wee et al.
2000
║33
Self-report,
standard 5
categories
Self-report of
mammogram in
last 2 years
Adjusted
difference in
proportion
Normal 0, overweight -2.8
(-6.7 to 0.9), class I -5.3
(-11.1 to 0.5), class II -4.5
(-12.5 to 3.4), class III -8.8
(-22.9 to 5.3)
Age, race, education, marital
status, region of country,
health status, health-care
use, hospitalization, days
in bed, insurance type,
physician specialty
Wee et al.
2004
║32
Self report,
standard 5
categories
Self-report of
mammogram in
last 2 years
RR Normal 1.00, overweight 1.01
(0.95 to 1.06), class I 0.99 (0.91
to 1.05), class II 0.89 (0.77 to
1.01), class III 0.88 (0.71 to 1.01)
Age, race, education, marital
status, region of country,
health-care access, health
status, co-morbid conditions,
mobility, hospitalization
Winkleby
et al. 2003
34
Self-report,
standard
5 categories
‡
Self-report of
mammogram in
last year
OR Normal 1.00, overweight 1.03
(0.41 to 2.62), class I 0.85
(0.25 to 2.89), class II
2.94 (0.42 to 20.61), class III
0.59 (0.06 to 5.79)
Age, education, marital status,
years in US
Zhu et al.
2006
║35
Self-report,
standard 5
categories
Self-report of
no screening
mammogram in
last 2 years**
OR Normal 1.00, overweight 0.9
(0.8 to 1.1), class I 0.9 (0.8 to
1.1), class II 1.0 (0.8 to 1.3),
class III 1.3 (1.0 to 1.8)
Age, race, education, marital
status, income, employment,
smoking, alcohol, skin cancer
exam, health status, co-morbid
conditions, days in bed, need
for special equipment, functional
limitations, home health-care,
recent surgery, status of walking,
moving, lifting, and carrying,
medical care visits, insurance
*Standard two categories of BMI: non-obese <30 kg/m
2 and obese ≥30 kg/m
2; standard five categories of BMI: normal 18–24.9 kg/m
2, overweight 25–
29.9 kg/m
2, class I obesity 30–34.9 kg/m
2, class II obesity 35–39.9 kg/m
2, class III obesity ≥ 40 kg/m
2
†Adjusted results reported with the exception of Amy et al.
28
‡Obtained data in standard five categories upon request from author
§Result of chi-square test
║Studies included in main, unstratified meta-analysis
¶Unclear which statistical test used by authors to obtain reported P value
#Study used lack of mammogram as an outcome
**P value for trend
BMI, body mass index; CI, confidence interval; OR, odds ratio; SES, socioeconomic status; RR, relative risk
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Author Missing data Exposure description Outcome description Confounding Validity Response rate
Amonkar et al. 2002
27 NR Adequate Fair Adequate NR
† NR
Amy et al. 2006
28 <10% Adequate Adequate Inadequate Fair NR
Berz et al. 2008
38 >20% Adequate Adequate Adequate NR
† NR
Cohen et al. 2007
36 <10% Adequate Adequate Adequate NR NR
Coughlin et al. 2004
29 None Adequate Adequate Adequate NR
† 55.2%
Ferrante et al. 2006
40 >20% Adequate Adequate Adequate N/a N/a
Ferrante et al. 2007
37 NR Adequate Adequate Adequate NR
‡ 72%
Fontaine et al. 1998
41 NR Adequate Adequate Adequate NR
‡ 87%
Fontaine et al. 2001
30 <10% Adequate Adequate Adequate NR
† NR
Gorin et al. 2001
42 None Adequate Adequate Fair Referred to other
reference for details
of Harlem Survey used
72%
Ostbye et al. 2005
31 NR Adequate Adequate Adequate NR
§ 84.7%
Rosenberg et al. 2005
39 NR Adequate Adequate Adequate NR 61.7%
Satia et al. 2007
43 NR Adequate Adequate Fair NR 17.5%
Wee et al. 2000
33 NR Adequate Adequate Adequate NR
‡ 94% for NHIS overall;
88% for supplement
║
Wee et al. 2004
32 <10% Adequate Adequate Adequate NR
‡ 90% for NHIS overall;
73% for Family
Core and supplement
¶
Winkleby et al. 2003
34 <10% Adequate Adequate Adequate Fair 87%
Zhu et al. 2006
35 NR Adequate Adequate Adequate NR
‡ 72%
*Quality rating based on scale: inadequate, fair, adequate
†Study based on the Behavioral Risk Factor Surveillance System
‡Study based on the National Health Interview Survey
§Study based on the Health and Retirement Study
║Participants given an additional questionnaire regarding preventive health-care service use
¶Participants given additional questionnaires inquiring about height, weight, medical conditions, sociodemographics, health status, health-care utilization,
health habits, tobacco use, physical activity, functional status, and cancer screening
NR, not reported; NHIS, National Health Interview Survey
Overall
Zhu 2006
Ostbye 2005**
Fontaine 2001
Author,Year
Wee 2004
Ostbye 2005*
Wee 2000
Berz 2008
1.01 (0.95, 1.08)
1.11 (0.95, 1.30)
1.13 (0.79, 1.62)
1.00 (0.94, 1.07)
OR (95% CI)
1.04 (0.85, 1.27)
0.90 (0.78, 1.04)
0.88 (0.74, 1.05)
1.08 (1.01, 1.15)
1.01 (0.95, 1.08)
1.11 (0.95, 1.30)
1.13 (0.79, 1.62)
1.00 (0.94, 1.07)
OR (95% CI)
1.04 (0.85, 1.27)
0.90 (0.78, 1.04)
0.88 (0.74, 1.05)
1.08 (1.01, 1.15)
1 .5 1 1.5 2
Overweight
Overall
Wee 2000
Ostbye 2005*
Zhu 2006
Fontaine 2001
Berz 2008
Ostbye 2005**
Wee 2004
Author,Year
0.93 (0.83, 1.05)
0.79 (0.64, 0.99)
0.73 (0.60, 0.88)
1.11 (0.95, 1.30)
0.89 (0.81, 0.98)
1.08 (0.99, 1.18)
0.97 (0.65, 1.45)
0.96 (0.76, 1.23)
OR (95% CI)
0.93 (0.83, 1.05)
0.79 (0.64, 0.99)
0.73 (0.60, 0.88)
1.11 (0.95, 1.30)
0.89 (0.81, 0.98)
1.08 (0.99, 1.18)
0.97 (0.65, 1.45)
0.96 (0.76, 1.23)
OR (95% CI)
1 .5 1 1.5 2
Class I Obesity
Overall
Zhu 2006
Ostbye 2005*
Berz 2008
Author,Year
Fontaine 2001
Wee 2000
Ostbye 2005**
Wee 2004
0.90 (0.78, 1.04)
1.00 (0.78, 1.27)
0.69 (0.51, 0.93)
1.10 (0.97, 1.24)
OR (95% CI)
0.88 (0.76, 1.01)
0.82 (0.57, 1.17)
1.03 (0.61, 1.75)
0.69 (0.47, 1.02)
0.90 (0.78, 1.04)
1.00 (0.78, 1.27)
0.69 (0.51, 0.93)
1.10 (0.97, 1.24)
OR (95% CI)
0.88 (0.76, 1.01)
0.82 (0.57, 1.17)
1.03 (0.61, 1.75)
0.69 (0.47, 1.02)
1 .5 1 1.5 2
Class II Obesity
Overall
Zhu 2006
Wee 2004
Ostbye 2005*
Fontaine 2001
Wee 2000
Ostbye 2005**
Berz 2008
Author,Year
0.79 (0.68, 0.92)
0.77 (0.57, 1.03)
0.67 (0.42, 1.07)
0.59 (0.40, 0.87)
0.76 (0.63, 0.92)
0.69 (0.43, 1.10)
1.07 (0.60, 1.92)
0.97 (0.84, 1.13)
OR (95% CI)
0.79 (0.68, 0.92)
0.77 (0.57, 1.03)
0.67 (0.42, 1.07)
0.59 (0.40, 0.87)
0.76 (0.63, 0.92)
0.69 (0.43, 1.10)
1.07 (0.60, 1.92)
0.97 (0.84, 1.13)
OR (95% CI)
1 .5 1 1.5 2
Class III Obesity
Figure 2. Meta-analyses of nationally representative studies with BMI in five categories. Note: Included studies:
30–33,35,38; BMI categories:
overweight 25–29.9 kg/m
2, class I obesity 30–34.9 kg/m
2, class II obesity 35–39.9 kg/m
2, class III obesity ≥40 kg/m
2. *Data from analysis of
white women.
**Data from analysis of black women. BMI, body mass index; OR, odds ratio; CI, confidence interval.
671 Maruthur et al.: Obesity and Mammography JGIMincluding three that were not based on nationally representative
surveys (data not shown)
30–36,38,40.
Effect of Race
Five nationally representative studies
30–33,35 evaluated the
effect of race on the relationship between BMI and recent
mammography. Compared to women with a normal BMI,
meta-analyses of the three race-stratified studies using five
categories of BMI
31,32,35 revealed an inverse association be-
tween class II and III obesity and recent mammography for
white women, but a positive association between overweight
and recent mammography among black women (Table 4). We
found statistical evidence of heterogeneity for class I obesity in
the analyses for white women and for class I and II obesity in
the analyses for black women. There was no statistical
evidence of publication bias.
Four studies conducted in primarily non-white populations
did not find a statistically significant association between BMI
and recent mammography
34,39,42,43. One study based on a
chart review of patients (86% non-white) of urban family
practices reported an increased odds of recent mammography
among overweight and class II obese patients compared to
patients with a normal BMI
40. A study of baseline data from
the Southern Community Cohort Study found that compared
to women with a normal BMI, white women with class III
obesity were less likely to report recent mammography, but
overweight and class I and II obese black women were more
likely to report recent mammography
36.
DISCUSSION
This systematic review demonstrates an inverse relationship
between class I, II, and III obesity and recent mammography
that was statistically significant for class III obesity. Compared
to their lean counterparts, women with class III obesity were
20% less likely to report recent mammography. In white
women, we found a statistically significant negative associa-
tion between class II and III obesity and being up-to-date with
mammography. We did not find this association between BMI
and mammography among black women.
Two of the three studies that did not report an inverse
association between recent mammography and increasing BMI
were not nationally representative. One was a chart review
from family practices in New Jersey with primarily non-white
patients
40, and the other was a Harlem survey among mostly
non-Hispanic blacks
42. The findings of these two studies are
consistent with the results of our meta-analyses in which we
observed no significant inverse relationship between obesity
and mammography in non-whites. The third negative study
41
included women <40 years of age. These results may be
confounded by age since younger women are more likely to
have a lower BMI
54 and to report a lower prevalence of
mammography since it is not routinely recommended for
them.
Obese women may experience several possible barriers to
mammography. Prior data show that obese women may delay
medical care
55 because of poor self-esteem and body image,
embarrassment
29,30,55,56, a perceived lack of respect from
health-care providers, or to avoid unwanted weight loss
advice
28. Obesity may be a marker for sub-optimal health
behavior in general, of which lack of mammography is simply
one facet
30,33. Also, beliefs regarding cancer screening may
vary by BMI
33. There could be physical limitations to obtaining
mammography for obese women, but obesity is associated with
a higher content of fat in the breast tissue that actually
increases the sensitivity of mammography for detecting breast
cancer
57,58. Finally, obesity is associated with lower socioeco-
nomic status
59, which may decrease access to preventive care.
There are also many physician-related factors that may
decrease screening mammography among obese women. Obe-
sity-related co-morbid conditions may hinder referral for
purely preventive services
41,60,61. In addition, providers have
reported difficulty and inadequate resources and education in
providing care for obese women
28. Finally, physicians may have
biases against obese women, resulting in less screening
62–64.
Obesity did not appear to affect the report of recent
mammography in black women. This may be due to racial
differences in obesity-related body image
65–67. In particular, it
has been reported that overweight or obese white, but not
black, women were more likely to feel worthless, which may
impact willingness to undergo mammography
32. Black women
may have a similar risk of developing breast cancer
68,69, but
higher breast cancer mortality
21,68–71. They tend to present
with a higher stage of breast cancer
69,71, which has been
linked to (1) less follow-up for abnormal exams
72, (2) higher
rates of obesity
72–75, (3) socioeconomic factors
76, (4) cultural
beliefs (e.g., belief in herbal treatments)
76, and possibly, lower
likelihoodofscreening
77–79, althoughthis iscontroversial
68,80–82.
Our findings, the first meta-analyses by race, suggest that rates
of mammography in black women do not vary significantly by
BMI.
We included only 6 of 17 studies in our meta-analyses based
on the provision of unique nationally representative data and
BMI in five standard categories. However, 14 of the 17 studies
reported a negative association between BMI and report of
mammography. Also, we obtained similar results when we
Table 4. Combined Odds Ratios for Mammography by BMI for
Race-Stratified Analyses
*†
BMI category Combined odds ratios (95% CI) I
2 (%)
‡
White women
Normal 1.00 (reference)
Overweight 0.98 (0.85 to 1.13) 49
Class I obesity 0.84 (0.69 to 1.02) 60
Class II obesity 0.73 (0.56 to 0.95) 47
Class III obesity 0.67 (0.53 to 0.84) 0
Black women
Normal 1.00 (reference)
Overweight 1.28 (1.03 to 1.60) 0
Class I obesity 1.38 (0.90 to 2.12) 54
Class II obesity 1.46 (0.76 to 2.80) 66
Class III obesity 0.91 (0.62 to 1.33) 0
*Studies included:
31,32,35. Additional studies
30,33 evaluated the interac-
tion between race and BMI, but did not provide the quantitative results
necessary for inclusion in our meta-analyses. Fontaine et al. in 2001
30
provided a P value (P=0.908) for the interaction between race and
mammography, and Wee et al.
33 reported adjusted rate differences,
suggesting a possible decline in screening with BMI among white women,
but not among black women. We contacted the authors, but were unable
to obtain further results
†Adjusted odds ratios used in analysis
‡I
2 Statistic is a measure of heterogeneity with an I
2 >50% signifying
“substantial heterogeneity”
51
BMI, body mass index
672 Maruthur et al.: Obesity and Mammography JGIMincluded all nine studies that reported BMI in five standard
categories.
Most of the included studies were cross-sectional and
cannot establish causality, but it is unlikely that failure to
undergo mammography would contribute to weight gain. Also,
we relied on the use of observational studies, which are
susceptible to residual and unmeasured confounding. In
particular, socioeconomic factors and health behaviors may
confound the relationship between obesity and breast cancer
and are difficult to account for fully. Although we did not find
publication bias, we had limited power with a small number of
studies. However, our search also included articles in which
body weight was not the primary exposure, and thus, the
potential for publication bias should be low.
The included studies used self-report of BMI as the measure
of body weight, which has several limitations: It may underes-
timate obesity, especially in women
83, but may also overesti-
mate obesity, especially in blacks
83. Self-report of height and
weight may differ by survey type (telephone versus in-person),
age, and BMI
84. Overall, the included studies may have placed
more obese participants into less obese categories, which
would bias our results toward the null or result in finding an
inverse association in overweight or milder obesity. However,
the overall qualitative association between body weight and
mammography would be unchanged.
Most of the included studies also relied upon self-report of
mammography. A recent meta-analysis found that self-report
of mammography had a sensitivity of 93% and specificity of
62%
85. While this study reported similar sensitivities for self-
reported mammography in blacks and whites, the specificity of
self-reported mammography was only 49% among blacks
85.
Thus, mammography results are likely inflated above their
actual rates with the degree of inflation higher for blacks.
T h e r ei sn oe v i d e n c et h a tt h ea c c u r a c yo fs e l f - r e p o r to f
mammography varies by BMI, but if it does, our results would
also be biased.
The included studies did not stratify on menopausal status,
but only one study included women under the age of
40 years
41. It seems unlikely that menopausal status would
affect willingness to be screened in women over age 40. While
the relationship between obesity and premenopausal breast
cancer risk and mortality is unclear
10–12, obesity increases
postmenopausal breast cancer risk
10,11,13–15 and mortality
16–19.
Finally, our search strategy may have been susceptible to
selection bias given that we included a small number of full
articles from the total citations reviewed, we manually
searched only 11 key journals, and we had limited success
obtaining full results from contacted authors. However, the
qualitative results matched our meta-analytic results, we
included no new articles from the manual search of 11
journals, and we were very sensitive in promoting a title or
abstract to full article review (i.e., if an article discussed risk
factors associated with mammography, we promoted that to
full article review). Additionally, we re-reviewed a random
sample of 2.5% of the full articles excluded at title review and
5% of the full articles excluded at abstract review and did not
find any additional articles that satisfied our inclusion criteria.
Our study also has several strengths. This is the first
systematic review with meta-analyses exploring the relation-
ship between obesity and mammography and the only one to
examine the effect of race on this association. We comprehen-
sively searched multiple electronic databases in addition to
manual searching. Also, we contacted authors for data leading
to additional results from four studies. Finally, the meta-
analyses were based on nationally representative surveys and
thus are generalizable to the US population.
The main implication of our study is that a lack of routine
screening mammography may explain some of the increased
breast cancer mortality in obese postmenopausal women.
Clinicians should be aware of this disparity in evaluating their
own practices. Future research should determine why obese
women are less likely to report recent mammography, includ-
ing the investigation of a lack of health care access due to
perceived bias or lack of insurance as a possible cause and
explore whether there are consistent differences by race.
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APPENDIX
Table 5. Electronic Database Search Terms*
PubMed
Keywords MeSH terms
Breast cancer(s); breast neoplasm(s);
breast tumor(s); neoplasm(s), breast;
tumor(s), breast; cancer(s), breast;
cancer(s) of breast; cancer(s) of the
breast; mammary carcinoma(s) of
breast; mammary carcinoma(s), human;
carcinoma(s), mammary human; human
mammary carcinoma(s); mammary
neoplasm(s), human; human mammary
neoplasm(s); neoplasm(s), human
mammary; mammary neoplasm(s), human
Breast neoplasms
Breast cancer screening; mammogram;
mammography; mammographies;
screening mammography; screening for
breast cancer
Mammography
Body weight(s); weight; obesity; adiposity;
body mass index; Quetelet index; BMI;
overweight; body measure(s); measure(s),
body; index, body mass; index, Quetelet;
Quetelet's index; Quetelets index; body
weights and measures
Body weights
and measures
Cancer screening
CINAHL
Keywords CINAHL headings
Breast cancer, breast neoplasms Breast neoplasms
Breast cancer screening, mammography,
mammogram
Mammography
BMI, body mass index, obesity,
Quetelet index
Body weights and
measures
Cancer screening Cancer screening
Cochrane
Search all text MeSH terms
Breast cancer, breast neoplasms Breast neoplasms
Breast cancer screening, mammography,
mammogram
Mammography
BMI, body mass index, Quetelet index Body weights
and measures
Cancer screening
*Our overall search strategy addressed a broader question regarding the
association between obesity and screening for breast, cervical, and
colon cancer. This study focuses on the relationship between weight
and mammography
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Obesity and Cancer Screening
Quality Assessment Form
Reviewer: __________
Author/Year: ___________
Ref ID: _____
*Please check one answer for each question.
INTRODUCTION
1. Were objectives and pre-specified hypotheses reported?
_ adequate (objectives and pre-specified hypotheses were
reported)
_ fair (objectives specified but hypotheses not clearly stated)
_ inadequate (minimal or no description)
METHODS
2. Was the study setting described?
_ adequate (setting, location, and dates of data collection
stated)
_ fair (setting, location, and dates of data collection stated
incompletely)
_ inadequate (minimal or no description)
3. Was the study population described?
_ adequate (There was a complete description of methods
of selection and exclusion criteria OR statement that all
eligible patients enrolled.)
_ fair (There was an incomplete description of methods of
selection and exclusion criteria. Would be difficult to
replicate with the information provided)
_ inadequate (minimal or no description)
4. How was the study population selected?
_ random sampling
_ convenience sampling
_ consecutive selection
_ other purposive sampling
_ other (please specify.): ____________
_ not described
5. Was there information on excluded or non-participating
subjects?
_adequate(Allreasonsfor exclusionorlackofparticipation
noted OR no exclusions.)
_fair (There was some discussion of this topic, but not
sufficient to allow replication.)
_ inadequate (no description)
6. Was the exposure well-described?
_ adequate (exposure explicitly defined, and method of
measurement described)
_ fair (exposure described incompletely)
_ inadequate (no description)
7. Was the outcome well-described?
_ adequate (outcome explicitly defined, and method of
measurement described)
_ fair (outcome described incompletely)
_ inadequate (no description)
8. If the study involved medical record review, was there
standardized data abstraction?
_ yes (please specify.) __________________________________
_n o
_ not described
_ other (please specify) _________________________________
_ not applicable
9. If the study involved medical record review, was there
blinding of abstractors to the study question?
_ yes
_n o
_ not described
_ not applicable
_ other (please specify) _________________________________
10. If the study involved medical record review, was there a
description of handling of disagreements?
_ not applicable
_ adequate (method for handling of disagreements de-
scribed completely)
_ fair (method for handling of disagreements described
incompletely)
_ poor(methodfor handingofdisagreements notdescribed)
11. If data abstracted from medical records, was inter- and
intra-rater reliability described?
_ not applicable
_ inter-rater reliability
_ yes
_ kappa (please list) _______
_ other (please list) ________
_n o
_ other (please specify) ___________
_ intra-rater reliability
_ yes
_ kappa (please list) _______
_ other (please list) ________
_n o
_ other (please specify) ___________
12. If the study used a survey, was the survey response rate
reported?
_ not applicable
_ not reported
_ rate reported (please list) _____________________________
13. Were key baseline characteristics ascertained?
I. age
II. sex
III. comorbidity
IV. socioeconomic factors
V. family history
VI. race
VII. smoking status
_ adequate (0–2 applicable categories not described)
_ fair (2–3 applicable categories not described)
_ inadequate (>3 applicable categories not described)
676 Maruthur et al.: Obesity and Mammography JGIM14. How did the study report the numbers of individuals at
each stage of the study? (e.g., number of potentially
eligible, examined for eligibility, confirmed eligible, included
in the study, completed follow-up, and analyzed)
_ adequate
_ fair (one of the above not described)
_ inadequate (>1 not described)
15. For what percentage of participants were there missing data?
_ none
_ <10%
_1 0 –20%
_ >20%
_ not reported
_ n/a
16. Was there a discussion of sample size rationalization?
_ adequate (Practical and statistical considerations were
described.)
_ fair(Rationale forsamplesizewasdiscussedincompletely.)
_ inadequate (Rationale for sample size not discussed.)
17. Were statistical analyses clearly described?
_ adequate (described for all analyses)
_ fair (described for some analyses)
_ inadequate (not described)
18. For main analyses, were numbers of individuals experi-
encing the outcome reported?
_ adequate (numbers provided or can be calculated for
outcomes)
_ fair (proportions but not numbers provided for outcomes)
_ inadequate (no enumeration of outcome provided)
19. For main analyses, are there estimates and a measure of
variability (e.g., standard error, standard deviation, con-
fidence intervals) reported?
_ adequate (estimates and variability reported)
_ fair (estimates and p-value or test statistic reported)
_ inadequate (estimate only reported)
20. Were confounding factors treated adequately?
_ a d e q u a t e( A d j u s t m e n t sw e r em a d ef o rm o s to ra l l
potential confounders.)
_ fair (Adjustments were made for most confounders.)
_ inadequate (There were minimal or no adjustments for
confounding.)
21. Were methods for use of quantitative variables explained?
_ adequate (description of covariates present)
_ inadequate (description of covariates not present)
CONFLICTS OF INTEREST
22. Were sources of funding identified?
_ adequate (source of funding or no funding specified)
_ poor (funding not described)
Other comments on study quality:
_________________________________________________________
_________________________________________________________
_________________________________________________________
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